Table 3. Outcomes according to treatment received.
| Study | Mortality | Stroke (%) | Infection (%) | Cost (USD) | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Early (%) | Late (%) | Total cost per patient | Cost per lived year | ||||||||||||||||||||
| BTT | DT | HTx | BTT | DT | HTx | BTT | DT | HTx | BTT | DT | HTx | BTT | DT | HTx | BTT | DT | HTx | ||||||
| Ammirati, 2015 | 11 | 11 | 16.3 | 6.7 | 6.7 | 8.2 | 1.4 | 1.4 | 6.1 | 13 | 13 | 26.5 | NA | NA | NA | NA | NA | NA | |||||
| Schumer, 2015 | 3 | – | 4 | 11 | – | 11 | NA | – | NA | NA | – | NA | NA | – | NA | NA | – | NA | |||||
| Droogne, 2014 | NA | NA | 0 | 16 | 23 | 17 | NA | NA | NA | NA | NA | 21.1 | 95.4 | NA | 152.9 | 11.5 | 226.9 | 174.7 | |||||
| Attisani, 2012 | 40 | – | 4.3 | 34.8 | – | 21.7 | NA | - | NA | NA | NA | NA | NA | – | NA | NA | – | NA | |||||
| Sorabella, 2015 | 12.8 | 13 | 16.3 | 4.3 | 4.4 | 7 | 4.3 | 8.7 | 4.7 | 25.5 | 26.1 | 32.6 | NA | NA | NA | NR | NA | NR | |||||
| Williams, 2011 | 0 | 0 | 0 | 0 | – | 10.4 | 0 | – | 0 | NA | – | NA | 166.4 | – | 230.1 | NA | – | NA | |||||
| Jakovljevic, 2014 | 0 | 0 | 0 | 0 | – | 12.5 | NA | NA | NA | NA | – | 7 | NA | – | NA | NA | – | NA | |||||
| Mishra, 2016 | 0 | 13 | 4 | 9 | 48 | 92 | 0 | 0 | 0.5 | 0 | 0 | 0.5 | 156.9 | – | 128.5 | 52.3 | – | 42.8 | |||||
Early mortality, 30-day; late mortality, 1-year.